Evidence map›Paper›PMID 22836369›Full record

ArticlePsychopharmacology2013

Acute cocaine induced deficits in cognitive performance in rhesus macaque monkeys treated with baclofen.

Linda J Porrino, Robert E Hampson, Ioan Opris, Samuel A Deadwyler

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. PGx-BasedCurrent neuropharmacology · 2026
    Article
  2. Article
  3. Residual deficits in functional brain activity after chronic cocaine self-administration in rhesus monkeys.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. GABA levels in the dorsal anterior cingulate cortex associated with difficulty ignoring smoking-related cues in tobacco-dependent volunteers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Linda J PorrinoDepartment of Physiology and Pharmacology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA.
Robert E Hampson
Ioan Opris
Samuel A Deadwyler
Wake Forest University · US

Funding

TROPANE EVALUATION AND GENERAL SCIENTIFIC SERVICES COREP50DA006634 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PORRINO, LINDA J. · 1991 to 2019
$30.8M
Neuronal Analysis of Cocaine Effects on CognitionR01DA023573 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DEADWYLER, SAMUEL A. · 2007 to 2011
$1.6M
Neuroimaging Correlates of Cocaine Reinforcement for Cognitive PerformanceR01DA026487 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DEADWYLER, SAMUEL A. · 2010 to 2014
$1.6M
NIDA NIH HHS DA023573NIDA NIH HHS DA026487NIDA NIH HHS DA06634NIDA NIH HHS P50 DA006634NIDA NIH HHS R01 DA023573NIDA NIH HHS R01 DA026487
6 · The paper itself

Abstract

rationaleAcute and/or chronic exposure to cocaine can affect cognitive performance, which may influence rate of recovery during treatment.

objectiveEffects of the GABA-B receptor agonist baclofen were assessed for potency to reverse the negative influence of acute, pre-session, intravenous (IV) injection of cocaine on cognitive performance in Macaca mulatta nonhuman primates.

methodsAnimals were trained to perform a modified delayed match to sample (DMS) task incorporating two types of trials with varying degrees of cognitive load that had different decision requirements in order to correctly utilize information retained over the delay interval. The effects of cocaine (0.2, 0.4, and 0.6 mg/kg, IV) alone and in combination with baclofen (0.29 and 0.40 mg/kg, IV) were examined with respect to sustained performance levels. Brain metabolic activity during performance of the task was assessed using PET imaged uptake of [(18) F]-fluorodeoxyglucose.

resultsAcute cocaine injections produced a dose-dependent decline in DMS performance selective for trials of high cognitive load. The GABA-receptor agonist baclofen, co-administered with cocaine, reversed task performance back to nondrug (saline IV) control levels. Simultaneous assessment of PET-imaged brain metabolic activity in prefrontal cortex (PFC) showed alterations by cocaine compared to PFC metabolic activation in nondrug (saline, IV) control DMS sessions, but like performance, PFC activation was returned to control levels by baclofen (0.40 mg/kg, IV) injected with cocaine.

conclusionsThe results show that baclofen, administered at a relatively high dose, reversed the cognitive deficits produced by acute cocaine intoxication that may have implications for use in chronic drug exposure.

Indexed as

AnimalsBaclofenBrainCocaineCognitionCognition DisordersDose-Response Relationship, DrugFluorodeoxyglucose F18GABA-B Receptor AgonistsInjections, IntravenousMacaca mulattaMalePositron-Emission TomographyPrefrontal CortexRadiopharmaceuticalsBaclofenCocaineFluorodeoxyglucose F18GABA-B Receptor AgonistsRadiopharmaceuticals

Identifiers

PMID22836369
PMCPMC3801229
OpenAlexW2007961051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.